Close Menu

NEW YORK(GenomeWeb) – Cowen & Co. today upgraded shares of Fluidigm to Outperform, noting the company's strong base business and improvement in its DVS business. 

Also, William Blair upgraded Hologic shares to Outperform, citing changes to the firm's management. 

Cowen analyst Douglas Schenkel upgraded Fluidigm's shares from a previous Market Perform rating and increased the price target on the stock to $40 from $32. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Wired reports on how genetic genealogy's use in forensics has exploded in the year since an arrest in the Golden State Killer case was made.

Retraction Watch reports that the increase in retracted papers at a journal is due to more resources there to tackle publication ethics.

New York City has settled with a forensic scientist who was fired after questioning a DNA testing approach used by the medical examiner's office, the New York Times reports.

In Nature this week: technique for measuring replication fork movement, WINTHER trial results, and more.